hyperkalemia/edema

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 168 rezilta yo

Nondialytic management of hyperkalemia and pulmonary edema among end-stage renal disease patients: an evaluation of the evidence.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Congestive heart failure (CHF) and hyperkalemia are the two leading reasons for emergency dialysis among individuals with end-stage renal disease (ESRD). While hemodialysis provides definitive treatment of both hyperkalemia and volume overload among ESRD patients, for those who present outside of

[Current use of acetazolamide as a diuretic: usefulness in refractory edema and in aldosterone-antagonist-related hyperkalemia].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Use of spironolactone in renal edema. Effectiveness and association with hyperkalemia.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Hyperkalemia and coma associated with renal tubular acidosis in an old patient with refractory edema due to the nephrotic syndrome: furosemide-bicarbonate therapy.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Hyperkalemia induced E.C.B. abnormalities and pulmonary edema: its improvement on hemodialysis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

[Pulmonary edema caused by heroin. Hemodynamic study of 2 cases].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The authors report two cases of heroin induced pulmonary edema. In both cases the severity of respiratory failure, attested by a deep hypoxemia (paO2 28 and 32 mmHg) and a metabolic and respiratory acidosis (pH 7.07 and 7.14) imposed an artificial ventilation with positive end expiratory pressure

Hyperkalemia in acute glomerulonephritis due to transient hyporeninemic hypoaldosteronism.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Transient hyperkalemia has been reported to occur in patients with acute glomerulonephritis, but the pathogenetic mechanism has not been investigated systematically. We studied the mechanism of hyperkalemia (5.7 to 6.7 mmol/liter) in four men with post-infectious glomerulonephritis. All four

New drugs to prevent and treat hyperkalemia.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Hyperkalemia is frequent, but occurs mostly in patients with chronic kidney disease and is often the cause of discontinuation or omission of renin-angiotensin-aldosterone system inhibitors in patients with diabetes, chronic kidney disease and heart failure. Without much evidence in the literature on

Pharmacodynamics and pharmacokinetics of sodium zirconium cyclosilicate [ZS-9] in the treatment of hyperkalemia.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Hyperkalemia is a common electrolyte disorder that arises from dysfunctional homeostatic mechanisms or as a consequence of decreased renal function. Sodium zirconium cyclosilicate (ZS-9) is a potential new therapy for hyperkalemia in both acute and chronic settings. METHODS Here we

Etoricoxib-induced life-threatening hyperkalemia and acute kidney dysfunction against the background of telmisartan and a low sodium diet.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Drug-induced hyperkalemia is not uncommon and may be life-threatening when presenting acutely in the emergency department. We present a case of severe hyperkalemia precipitated acutely by etoricoxib in a patient who was on telmisartan and a low sodium (potassium chloride-rich) diet. A 75-year-old

Sodium zirconium cyclosilicate: a new potassium binder for the treatment of hyperkalemia.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Hyperkalemia is one of the most common electrolyte disturbances, especially among some groups of patients, such as in those with chronic kidney disease, diabetes or heart failure. Hyperkalemia has been associated with increased risks of mortality, arrhythmias, hospitalization and costs, as well as

Amiloride resolves resistant edema and hypertension in a patient with nephrotic syndrome; a case report.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Sodium and fluid retention is a hallmark and a therapeutic challenge of the nephrotic syndrome (NS). Studies support the "overfill" theory of NS with pathophysiological proteolytic activation of the epithelial sodium channel (ENaC) which explains the common observation of suppressed renin

Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Serial measurements of plasma volume and ascites volume were made during treatment with large doses of oral diuretics in 14 patients with stable chronic liver disease. Eight patients had pitting edema in addition to ascites. Reproducibility of ascites and plasma volume measurements was verified in

Sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Hyperkalemia is a common, sometimes fatal electrolyte abnormality seen in patients with heart failure (HF) or kidney disease. Acute treatments that cause the intracellular translocation of potassium can be effective in the short-term but they simply buy time until definitive removal by

Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Hyperkalemia is a serious medical condition that often manifests in patients with chronic kidney disease and heart failure. Renin-angiotensin-aldosterone system inhibitors are known to improve outcomes in these disease states but can also cause drug-induced hyperkalemia. New therapeutic

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye